Syneos Health Schedules First Quarter 2022 Earnings Call for Friday, April 29th, 2022
Syneos Health (Nasdaq:SYNH) will announce its first quarter 2022 financial results on April 29, before an earnings call scheduled for 8:00 a.m. ET. A live webcast will be available via the Investor Relations section of their website, with telephone participation requiring prior registration. A replay of the webcast will be accessible after 1:00 p.m. on the same date. As a fully integrated biopharmaceutical solutions organization, Syneos Health focuses on expediting customer success through a product development mindset and a strategic integration of clinical and commercial capabilities.
- Scheduled earnings call for Q1 2022 on April 29, indicating transparency in financial reporting.
- Syneos Health is a fully integrated biopharmaceutical solutions organization, potentially appealing to investors.
- None.
MORRISVILLE, N.C., April 11, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success, will release its first quarter 2022 financial results on Friday, April 29th, 2022, prior to its earnings call at 8:00 a.m. ET
Participants may access the conference call live via webcast on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A webcast replay will be available on the Investor Relations section of the Syneos Health website at investor.syneoshealth.com after 1:00 p.m. on April 29th, 2022.
About Syneos Health
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. We lead with a product development mindset, strategically integrating clinical development, medical affairs and commercial capabilities to address modern market realities.
We bring together approximately 28,000 minds, across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.
Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
| Investor Relations Contact: Ronnie Speight Senior Vice President, Investor Relations +1 919 745 2745 Investor.Relations@syneoshealth.com | Press/Media Contact: Gary Gatyas Executive Director, External Communications +1 908 763 3428 gary.gatyas@syneoshealth.com |
FAQ
When will Syneos Health release its Q1 2022 financial results?
What time is the Syneos Health earnings call?
How can I access the Syneos Health earnings call?
Is there a replay available for the Syneos Health earnings call?
